Smile Invest Acquires Majority Stake in Alphatron Medical to Boost Growth

Smile Invest has acquired a majority stake in Alphatron Medical, a healthcare technology firm specializing in smart mobile nursing stations. The transaction, announced on June 30, 2026, brings Smile Invest together with Alphatron’s co-founder and CEO Harald Verloop, Alphatron Holding, and management to support the company’s next phase of growth across Europe and international markets.

While the financial terms of the deal remain undisclosed, the partnership aims to leverage Smile Invest’s healthcare investment expertise and network to expand Alphatron Medical’s footprint. The deal structure involves Smile Invest taking majority ownership alongside continued involvement from Alphatron’s founding team and existing shareholders.

Alphatron Medical develops integrated healthcare solutions that optimize nursing and medication workflows. Its flagship product, SmartCart, connects Electronic Health Records (EHR), medication administration, vital signs monitoring, and clinical documentation into a unified, secure workflow. The SmartConnect software platform integrates hardware, software, and workflows into a seamless ecosystem, enabling interoperability with hospital systems and automated dispensing cabinets for closed-loop medication management.

Harald Verloop, co-founder and CEO of Alphatron Medical, highlights the uniqueness of their solution: “We have built something truly unique at Alphatron Medical – a complete, integrated solution that makes the daily work of nurses safer and more efficient, one patient at a time. With Smile Invest as our partner, we gain not only the resources but also the strategic support and healthcare expertise to bring our solutions to more hospitals across Europe and beyond.”

Floris de Kort, Managing Director of Alphatron Holding, emphasized the importance of continuity: “By remaining involved alongside Smile Invest, Harald and management, we ensure that continuity both in values and ambition. We are confident this partnership will take Alphatron Medical to the next level.”

Smile Invest’s representatives, Davy Louwers and Nicolas Costers, noted the strategic fit: “Alphatron Medical is exactly the type of company we look for: an innovative market leader with a clear mission, a loyal customer base, and strong growth potential. Their integrated approach addresses critical challenges in modern hospitals, and we look forward to supporting their international expansion.”

The deal aligns with broader healthcare industry trends emphasizing digital transformation, patient safety, and workflow efficiency. Alphatron Medical’s solutions address pressing hospital needs by reducing manual tasks and minimizing medication errors through technology integration.

Financial details such as valuation multiples and funding sources were not disclosed. However, the partnership is expected to generate synergies through cross-selling Smile Invest’s portfolio to Alphatron’s hospital customers, accelerating international market penetration, and expanding integrated healthcare offerings combining hardware and software.

Operationally, the collaboration will focus on integrating the SmartConnect platform with Smile Invest’s existing healthcare technologies, enhancing workflow consultancy, and streamlining product development cycles. Challenges include aligning corporate cultures, managing complex hardware-software integration across diverse hospital IT systems, and navigating regulatory compliance in multiple markets.

Looking ahead, the partnership aims to strengthen Alphatron Medical’s position as a leading provider of smart nursing workflow solutions in Europe and new international markets. The combined expertise and resources are expected to drive innovation, improve patient safety, and expand service offerings.

Regulatory approvals and integration plans are underway, with both parties committed to a smooth transition and accelerated growth trajectory.